Unichem Pharmaceuticals USA Inc. recalls

3 recalls.

• busPIRone Hydrochloride Tablets recall (Unichem Pharmaceuticals USA Inc.)
  DrugClass IIIReported May 13, 2026 · Subpotent drug
• Doxazosin Tablets recall (Unichem Pharmaceuticals USA Inc.)
  DrugClass IIIReported February 18, 2026 · Tablets/Capsules Imprinted with Wrong ID
• Bisoprolol Fumarate and Hydrochlorothiazide tablets recall (Unichem Pharmaceuticals USA Inc.)
  DrugClass IIReported February 11, 2026 · cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.